6-Sulfanilamidoindazole arthritis: influence of alloxan diabetes, phenylbutazone and D-penicillamine on inflammatory size, sulfhydryl groups, diphenylamine reaction and enzymes of the serum.
D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001168:Arthritis / Q000139:chemically induced / Q000150:complications / Q000378:metabolism*; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000150:complications* / Q000378:metabolism; D004159:Diphenylamine; D004195:Disease Models, Animal; D007191:Indazoles; D008297:Male; D009113:Muramidase / Q000097:blood; D010396:Penicillamine / Q000494:pharmacology*; D010653:Phenylbutazone / Q000494:pharmacology*; D011720:Pyrazoles; D051381:Rats; D013424:Sulfanilamides; D013438:Sulfhydryl Compounds / Q000097:blood*
D001786:Blood Glucose; D007191:Indazoles; D011720:Pyrazoles; D013424:Sulfanilamides; D013438:Sulfhydryl Compounds; D004159:Diphenylamine; D000469:Alkaline Phosphatase; D009113:Muramidase; D010653:Phenylbutazone; D010396:Penicillamine